Peptidic supramolecular assemblies enhance chemotherapy for colorectal cancer

Colorectal cancer (CRC) has emerged as a frequently diagnosed disease. Advanced CRCs are highly heterogenous and often evade treatments, building drug resistance and reoccurring.